NanoViricides, Inc (NNVC) FinancialsNNVCNanoViricides, Inc

Evaluating the bottom line, NanoViricides, Inc maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -89.97%, provide a clear picture of how effectively NNVC converts its operational activities into shareholder value.

In the context of the broader market, NNVC competes directly with industry leaders such as ATNM and PPBT. With a market capitalization of $35.19M, it holds a leading position in the sector. When comparing efficiency, NNVC's gross margin of N/A stands against ATNM's 100.00% and PPBT's N/A. Such benchmarking helps identify whether NanoViricides, Inc is trading at a premium or discount relative to its financial performance.

The company has shown consistent losses, with a net income of -2220719.00 USD in Q2 2026 and a negative EPS of -0.11. The current ratio is strong at 4.43, indicating good short-term liquidity, but the overall financial performance is concerning due to ongoing losses.